second week of tirzepatide Weight-Loss Dosage Chart & Expectations Week 1 on Tirzepatide and

The Precision Peptide Genetic Test reveals predispositions in pathways including GIPR, GLP1R, FTO, and MC4R regulationgenetic variants that can influence inflammatory responsiveness and metabolic tolerance to peptide compounds

Hitachi)

The team was outstanding

Finicelli M, Digilio FA, Galderisi U, Peluso G

And when they do, the results don't stick

These include: Nausea (reported in approximately 24-30% of patients) Diarrhea (18-24% of patients) Vomiting (8-21% of patients) Constipation (16-24% of patients) Abdominal pain or discomfort Decreased appetite Dyspepsia/GERD (gastroesophageal reflux disease) Dizziness Hair loss (alopecia) These effects are typically most pronounced during dose escalation and often diminish over time as the body adjusts to the medication